Article

Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve

Herz-Kreislauf-Zentrum, Segeberger Kliniken GmbH, The Academic Teaching Hospital for the University of Kiel, Bad Segeberg, Germany.
Catheterization and Cardiovascular Interventions (Impact Factor: 2.4). 01/2009; 73(1):61-7. DOI: 10.1002/ccd.21744
Source: PubMed

ABSTRACT The association between aortic valve disease and coronary atherosclerosis is common. In the recent era of percutaneous aortic valve replacement (PAVR), there is little experience with coronary artery intervention after valve implantation.
To our knowledge, this is the first case of successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. We report a case of a 79-year-old female patient who underwent successful coronary artery intervention few months after a CoreValve's percutaneous implantation for severe aortic valve stenosis. Verifying the position of the used wires (crossing from inside the self expanding frame) is of utmost importance before proceeding to coronary intervention. In this case, crossing the aortic valve, coronary angiography, and multivessel stenting were successfully performed.
Percutaneous coronary intervention in patients with previous CoreValve is feasible and safe.

0 Followers
 · 
123 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The development of less invasive percutaneous techniques for aortic valve replacement to treat high-risk patients with severe aortic stenosis is a new challenge for cardiovascular therapists. Currently, there are two catheter-based treatment systems in clinical application (the Edwards SAPIEN aortic valve and the CoreValve ReValving System) utilizing either a balloon-expandable or a self-expanding stent platform, respectively. The immediate outcome and the midterm follow-up results available for both techniques confirm the safety and the applicability of these treatment modalities. Die Entwicklung weniger invasiver perkutaner Techniken zum Aortenklappenersatz in der Behandlung von Hochrisikopatienten mit schwerer Aortenklappenstenose stellt eine neue Herausforderung für den interventionellen Kardiologen dar. Gegenwärtig befinden sich zwei katheterbasierte Systeme in der klinischen Anwendung (die Edwards-SAPIEN-Aortenklappe und das CoreValveRe-Valving-System), die auf einer Ballon-expandierbaren bzw. selbst expandierenden Stentplattform basieren. Die bisher verfügbaren unmittelbaren und mittelfristigen Verlaufsergebnisse bestätigen die Sicherheit und Anwendbarkeit dieser Behandlungsverfahren.
    Clinical Research in Cardiology Supplements 05/2009; 4:102-107. DOI:10.1007/s11789-009-0061-4
  • Clinical Research in Cardiology Supplements 05/2009; 4:102-107.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Currently aortic valve replacement is performed for patients with severe aortic stenosis and symptoms or objective pathophysiologic consequences such as left ventricular dysfunction. For transcatheter mitral valve interventions, the complex pathophysiology of mitral regurgitation with varying causes along with challenging imaging and delivery issues has led to slower than anticipated clinical introduction. Transcatheter pulmonary valve intervention was primarily designed to treat the difficult problem of right ventricular to pulmonary artery conduit stenosis in the congenital population. These techniques are reviewed in this article.
    Surgical Clinics of North America 08/2009; 89(4):951-66, x. DOI:10.1016/j.suc.2009.06.004